Acadian Asset Management Portfolio holdings
AUM
$48.4B
1-Year Return
32.04%
This Quarter Return
+8.62%
1 Year Return
+32.04%
3 Year Return
+133.69%
5 Year Return
+272.69%
10 Year Return
+761.99%
AUM
$32.2B
AUM Growth
-$282M
(-0.87%)
Cap. Flow
-$1.8B
Cap. Flow
% of AUM
-5.59%
Top 10 Holdings %
Top 10 Hldgs %
23.59%
Holding
2,410
New
656
Increased
561
Reduced
741
Closed
336
Top Buys
| 1 |
Ericsson
ERIC
|
+$303M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$264M |
| 3 |
Citigroup
C
|
+$196M |
| 4 |
Fortinet
FTNT
|
+$162M |
| 5 |
Infosys
INFY
|
+$144M |
Top Sells
| 1 |
Pinduoduo
PDD
|
+$419M |
| 2 |
NVIDIA
NVDA
|
+$417M |
| 3 |
Amazon
AMZN
|
+$388M |
| 4 |
Meta Platforms (Facebook)
META
|
+$288M |
| 5 |
CRH
CRH
|
+$272M |
Sector Composition
| 1 | Technology | 34.81% |
| 2 | Financials | 16.08% |
| 3 | Communication Services | 9.48% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Healthcare | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Aligos Therapeutics
ALGS
$72M
| $263K | ﹤0.01% |
30,597
-2,582
| -8% | -$22.2K |
|
1277
Axcelis
ACLS
$2.68B
| $257K | ﹤0.01% |
+2,455
| New | +$257K |
|
1278
Janus Henderson
JHG
$7.04B
| $257K | ﹤0.01% |
6,773
+3,869
| +133% | +$147K |
|
1279
Toro Corp
TORO
$55.5M
| $257K | ﹤0.01% |
74,980
-27,845
| -27% | -$95.4K |
|
1280
HealthEquity
HQY
$7.97B
| $256K | ﹤0.01% |
+3,133
| New | +$256K |
|
|
ACHL
1281
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $255K | ﹤0.01% |
250,825
| – | – |
|
1282
Rhythm Pharmaceuticals
RYTM
$6.52B
| $254K | ﹤0.01% |
+4,858
| New | +$254K |
|
|
SANG
1283
Sangoma Technologies
SANG
$184M
| $254K | ﹤0.01% |
46,400
+7,384
| +19% | +$40.4K |
|
1284
Ionis Pharmaceuticals
IONS
$10.1B
| $253K | ﹤0.01% |
+6,328
| New | +$253K |
|
1285
Kadant
KAI
$3.73B
| $253K | ﹤0.01% |
+750
| New | +$253K |
|
1286
Origin Bancorp
OBK
$1.1B
| $252K | ﹤0.01% |
+7,863
| New | +$252K |
|
1287
American Superconductor
AMSC
$2.45B
| $251K | ﹤0.01% |
10,688
-113,800
| -91% | -$2.67M |
|
1288
Guardant Health
GH
$6.88B
| $251K | ﹤0.01% |
+10,969
| New | +$251K |
|
|
GMS
1289
DELISTED
GMS Inc
GMS
| $251K | ﹤0.01% |
2,774
-37,816
| -93% | -$3.42M |
|
1290
Merit Medical Systems
MMSI
$5.22B
| $251K | ﹤0.01% |
+2,544
| New | +$251K |
|
1291
Noble Corp
NE
$4.91B
| $248K | ﹤0.01% |
+6,877
| New | +$248K |
|
1292
Roivant Sciences
ROIV
$9.77B
| $248K | ﹤0.01% |
21,566
+13,056
| +153% | +$150K |
|
1293
Match Group
MTCH
$9.15B
| $247K | ﹤0.01% |
6,583
-62,739
| -91% | -$2.35M |
|
1294
Arcellx
ACLX
$4.35B
| $246K | ﹤0.01% |
+2,953
| New | +$246K |
|
1295
Paysign
PAYS
$292M
| $246K | ﹤0.01% |
+67,597
| New | +$246K |
|
1296
Movado Group
MOV
$433M
| $245K | ﹤0.01% |
+13,250
| New | +$245K |
|
|
API
1297
Agora
API
$342M
| $244K | ﹤0.01% |
103,152
+38,074
| +59% | +$90.1K |
|
1298
Axogen
AXGN
$765M
| $243K | ﹤0.01% |
17,378
-36
| -0.2% | -$503 |
|
1299
Crinetics Pharmaceuticals
CRNX
$3.19B
| $241K | ﹤0.01% |
+4,717
| New | +$241K |
|
1300
Cumberland Pharmaceuticals
CPIX
$51.9M
| $239K | ﹤0.01% |
188,164
| – | – |
|